NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 341 filers reported holding NEKTAR THERAPEUTICS in Q2 2019. The put-call ratio across all filers is 2.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $33,448 | -28.8% | 14,800 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $47,000 | -56.9% | 14,800 | -48.6% | 0.00% | -50.0% |
| Q2 2022 | $109,000 | -99.6% | 28,800 | -99.4% | 0.00% | -99.3% |
| Q1 2022 | $25,917,000 | -56.9% | 4,808,401 | +8.0% | 0.30% | -51.5% |
| Q4 2021 | $60,142,000 | -27.1% | 4,451,693 | -3.1% | 0.62% | -25.9% |
| Q3 2021 | $82,519,000 | +17.2% | 4,594,656 | +12.0% | 0.84% | +21.8% |
| Q2 2021 | $70,380,000 | -11.0% | 4,101,404 | +3.7% | 0.69% | -17.9% |
| Q1 2021 | $79,093,000 | +20.3% | 3,954,604 | +2.3% | 0.84% | +11.2% |
| Q4 2020 | $65,726,000 | +9.1% | 3,866,258 | +6.4% | 0.75% | -9.6% |
| Q3 2020 | $60,261,000 | -26.4% | 3,632,358 | +2.8% | 0.83% | -28.1% |
| Q2 2020 | $81,871,000 | +31.6% | 3,535,013 | +1.4% | 1.16% | -3.9% |
| Q1 2020 | $62,202,000 | -15.7% | 3,484,713 | +2.0% | 1.21% | +3.2% |
| Q4 2019 | $73,756,000 | +27.6% | 3,416,998 | +7.7% | 1.17% | +8.7% |
| Q3 2019 | $57,794,000 | -38.3% | 3,172,886 | +20.5% | 1.08% | -32.8% |
| Q2 2019 | $93,671,000 | +548.3% | 2,632,686 | +512.2% | 1.60% | +101.1% |
| Q1 2019 | $14,449,000 | +68.3% | 430,026 | +64.6% | 0.80% | +40.7% |
| Q4 2018 | $8,586,000 | +153.7% | 261,210 | +370.5% | 0.56% | +162.8% |
| Q3 2018 | $3,384,000 | +100.8% | 55,520 | +60.9% | 0.22% | +49.3% |
| Q2 2018 | $1,685,000 | -55.3% | 34,500 | -2.8% | 0.14% | -61.5% |
| Q1 2018 | $3,772,000 | -15.4% | 35,500 | -52.5% | 0.37% | -19.7% |
| Q4 2017 | $4,461,000 | +51.1% | 74,700 | -39.3% | 0.47% | +50.8% |
| Q3 2017 | $2,952,000 | +251.0% | 123,000 | +186.0% | 0.31% | +212.1% |
| Q2 2017 | $841,000 | -79.2% | 43,000 | -75.0% | 0.10% | -81.6% |
| Q1 2017 | $4,036,000 | +76.9% | 172,000 | -7.5% | 0.54% | +15.2% |
| Q4 2016 | $2,282,000 | -28.6% | 186,000 | 0.0% | 0.47% | -19.1% |
| Q3 2016 | $3,195,000 | +20.7% | 186,000 | 0.0% | 0.58% | +15.9% |
| Q2 2016 | $2,647,000 | -10.9% | 186,000 | -13.9% | 0.50% | -7.6% |
| Q1 2016 | $2,970,000 | – | 216,000 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |